For all press and media enquiries please contact mediarelations@chiesi.com
Chiesi Farmaceutici S.p.A. Via Palermo 26, Parma 16 February — 18 May 2024 “The greatest commitment has been to embrace and respond to change, quickly adapting to changing internal and external contexts, and understanding the need for innovation ahead of time.” From the book “ 70 Years of Healthcare…
The company has been awarded for its 2022 Sustainability Report, at Palazzo Mezzanotte in Milan, headquarters of Borsa Italiana. Parma, December 18, 2023 – Chiesi, a research-oriented international biopharmaceutical group, was awarded the 59th Oscar di Bilancio for the Benefit Corporation category,…
Restore to Impact | Award Ceremony Casa della Musica Parma Domusforum 2023 ADI Design Museum Milan Restore to Impact Award Ceremony and Domusforum 2023. Two events for a reflection dedicated to the themes of urban regeneration and the future of cities. From the winning ideas of the Call for Ideas,…
Chiesi Group proudly shares its contribution to the thought-provoking series “The Climate and Us”, presented by the Global Climate and Health Alliance and produced for them by BBC StoryWorks. The climate crisis is a health crisis 1 impacting the health of people around the world especially those…
The event brings together the company’s key partners to discuss the best practices in terms of quality, service level, innovation, collaboration and Chiesi’s value chain sustainability journey; The 2023 “Partner Awards” will be dedicated to entities that particularly distinguished themselves in two…
New research from Chiesi analyses the economic burden for 23 rare diseases across five therapeutic areas in three EU Member States and will be launched during a panel at the World Orphan Drug Congress (WODC) in Barcelona, Spain. The panel hosted by Chiesi is titled, ‘Reducing the burden of rare…
For the first time in the Foundation's history, a week of work and meetings with local authorities, hospital directors, doctors and nurses from Burundi, Burkina Faso, Togo, and Benin. The Foundation is active in the field of international health cooperation, through the transfer of scientific means…
A new survey, part of a report published by Economist Impact and supported by Chiesi, focuses on how respiratory patients experience the adverse effects of poor air quality. The report, result of a scoping literature review and survey, recognizes that climate-related factors have a significant…
Total of six poster presentations analyze the effects of treatment with enzyme replacement therapies in Fabry disease and alpha-mannosidosis; Company sponsoring symposium on advances in monitoring and management in Fabry disease. BOSTON (USA), September 1 st, 2023 – Chiesi Global Rare Diseases, a…
You are leaving the Chiesi Corp site to access another Chiesi site. Regulatory constraints and medical practices, as well as the information published on the site you are about to visit, may change from one country to another and may not comply with current Italian legislation on the subject.
You are about to leave our website and access an external site. By continuing, you agree to leave our site.
